OUR RESOURCES

Hepatocellular Carcinoma Update

Hepatocellular Carcinoma Update - 30 nov 2021

Welcome & Introduction

Epidemiology and diagnosis of HCC

Screening and Surveillance of HCC

Current Treatment and Challenges in HCC MX

Role of Tecentriq (Atezolizumab) + Avastin (Bevacizumab) As 1L in Unresectable HCC

Panel Discussion - Managing patients with Atezolizumab Bevacizumab combination in unresectable HCC